The ‘exceptional’ practice at Ropes & Gray LLP assists clients with a broad range of issues, including risk and crisis management, research and development strategies, and product life cycle management. The team acts for a number of notable clients, including Merck KGaA, Orphalan, and Allergan. With ‘unparalleled standing and credibility’, practice head Lincoln Tsang handles a myriad of issues, from internal investigations and public policy matters, to product approvals and clinical trials. Tsang also has a great deal of experience in interactions with the European Medicines Agency.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • 'Excellent expertise in regulatory law. I think the pharma practice is exceptional.'
  •  'Lincoln Tsang enjoys unparalleled standing and credibility in the life sciences sector based on his extensive experience both as a regulator and long-standing outside counsel to numerous bio-pharmaceutical and med tech companies.'
  • 'Lincoln Tsang is particularly experienced in market access and approval of medicines for rare diseases.'

Key clients

  • Bain Capital
  • NeoGenomics
  • Avista Capital Partners
  • Blackstone Group
  • Novavax
  • Pfizer
  • PTC Therapeutics
  • Takeda Pharmaceuticals International
  • Merck KGaA
  • Sarepta Therapeutics, Inc.
  • Chroma Medicine, Inc.
  • ConforMIS, Inc.
  • bluebird
  • Orphalan (previously Gmp-Orphan)
  • Horizon Therapeutics
  • BioMarin
  • Intrabio
  • Novavax
  • Pfizer
  • PTC Therapeutics
  • Nasus Pharma
  • Mirum Pharmaceuticals
  • Akebia Therapeutics, Inc.
  • Spruce Biosciences
  • Gyroscope Biotherapeutics
  • Ipsen Biopharmaceuticals
  • Kyowa Kirin Co.
  • Amicus Therapeutics
  • Allergan
  • Actimed Therapeutics

Work highlights

  • Advised GIC on its acquisition of a 40% interest in The Oxford Science Park from Magdalen College, and on the strategic joint venture between GIC and Magdalen College.
  • Advised Envision Pharma Group on its acquisition of OKRA.ai.
  • Advised Northpond Ventures on its further investment in the Series B shares of Refeyn.

Lawyers

Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.

Practice head

The lawyer(s) leading their teams.

Lincoln Tsang